%0 Case Reports
%T Exceptional Response to Olaparib and Pembrolizumab for Pancreatic Adenocarcinoma With Germline BRCA1 Mutation and High Tumor Mutation Burden: Case Report and Literature Review.
%A Lundy J
%A McKay O
%A Croagh D
%A Ganju V
%J JCO Precis Oncol
%V 6
%N 0
%D 01 2022
%M 35085003
%F 5.479
%R 10.1200/PO.21.00437
%X